Company Overview

PRIME exits and American HealthCare Capital is pleased to present a $12+ Million revenue specialty medical billing/revenue cycle management company for sale with customers primarily located in the MidAtlantic and Northeast regions of the United States. The company’s leadership is uniquely experienced in this particular physician specialty area of medical billing and RCM and, as such, has benefited from explosive growth that continues unabated.

Financial Overview

Between 2022 and 2023, revenues grew 50% from $5.7 million to $8.6 million. In 2024, revenues grew over 31% from the prior year to $11.3 million, and 2025 is on pace to achieve more than $12.0 million in revenues. Adjusted EBITDA (utilizing very conservative assumptions for a strategic buyer) was $662,364 in 2023, $2.1 million in 2024, and is on pace to achieve at least $2.2 million in 2025. The company has been adding payroll costs in anticipation of the start of several booked new contracts in the next few months. As such, the straight line run rate utilizing Q4 2025 projected financial results will conservatively result in $13 million in revenues and $2.44 million in unadjusted EBITDA.

The company boasts exceptional performance metrics including a First Pass Claims Rate of 98.3%, a net collection rate of 98.6%, and a bad debt rate of 1.1%. 

Staffing Overview and Exit Plan

The staff is almost exclusively based onshore and shares the same commitment and dedication to the company as the owners. The owners are open to staying on should the buyer desire continued assistance with not only the transition, but with realizing the future growth potential given such strong client demand.

Asking Price

The asking price for this opportunity is $22 Million.